DrugPatentWatch Database Preview

Roche Palo Company Profile

« Back to Dashboard

What is the competitive landscape for ROCHE PALO, and what generic and branded alternatives to ROCHE PALO drugs are available?

ROCHE PALO has fourteen approved drugs.

Summary for Roche Palo

US Patents:	0
Tradenames:	7
Ingredients:	9
NDAs:	14
Patent Litigation for Roche Palo:	See patent lawsuits for Roche Palo

Drugs and US Patents for Roche Palo

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche Palo	TICLID	ticlopidine hydrochloride	TABLET;ORAL	019979-001	Mar 24, 1993		DISCN	No	No
Roche Palo	TORADOL	ketorolac tromethamine	TABLET;ORAL	019645-001	Dec 20, 1991		DISCN	Yes	No
Roche Palo	CELLCEPT	mycophenolate mofetil	SUSPENSION;ORAL	050759-001	Oct 1, 1998	AB	RX	Yes	Yes
Roche Palo	CELLCEPT	mycophenolate mofetil	TABLET;ORAL	050723-001	Jun 19, 1997	AB	RX	Yes	Yes

Expired US Patents for Roche Palo

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche Palo	CYTOVENE	ganciclovir	CAPSULE;ORAL	020460-001	Dec 22, 1994	4,355,032
Roche Palo	CYTOVENE	ganciclovir	CAPSULE;ORAL	020460-001	Dec 22, 1994	4,423,050
Roche Palo	CELLCEPT	mycophenolate mofetil	SUSPENSION;ORAL	050759-001	Oct 1, 1998	4,753,935
Roche Palo	CYTOVENE	ganciclovir	CAPSULE;ORAL	020460-001	Dec 22, 1994	4,507,305

Paragraph IV (Patent) Challenges for ROCHE PALO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	For Oral Suspension	200 mg/mL		2011-03-25

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Roche
• Roche Palo